Japanese Red Cross Nagoya Daiichi Hospital
In research, Japanese Red Cross Nagoya Daiichi Hospital stands highest in Medicine (#9,229 of 10,443 worldwide) and Health Sciences (#11,008 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery — Surgery is 7.4× its share of world research.
- World rank, 2022–2025
- #24,623 of 28,054 · #29,558 all time
- Rank in Japan
- #828 of 1,070
- Research works
- 728 ▲ 22% vs 2013–17
- Citations
- 7.3k 10.0 per fractional work
- Top-10% rate
- 6.8% record average 16.5%
- Open access
- 52% world 28%
What is Japanese Red Cross Nagoya Daiichi Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,229 of 10,443 | 6.7% | 124 | #10158 | |
| Health SciencesDomain | #11,008 of 11,982 | 6.5% | 129 | #13195 |
Each strip is that field’s whole ranked pool, with the notch where Japanese Red Cross Nagoya Daiichi Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Japanese Red Cross Nagoya Daiichi Hospital specialise in?
Where its research is concentrated relative to its size: Surgery takes 7.4× the share of its output that it takes of world research.
- SurgerySubfield · 25.3 works7.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.
- Medicine 4.4×
- Dentistry 2.3×
- Veterinary 1.7×
- Immunology and Microbiology 1.3×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Nursing 1.2×
- Neuroscience 0.7×
- Health Professions 0.4×
- Psychology 0.2×
- Engineering 0.1×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
- Physics and Astronomy 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Arts and Humanities 0.1×
- Agricultural and Biological Sciences 0.0×
- Social Sciences 0.0×
- Computer Science 0.0×
- Economics, Econometrics and Finance 0.0×
- Environmental Science 0.0×
Who are the top researchers at Japanese Red Cross Nagoya Daiichi Hospital?
Ranked on the composite score, Eiji Takeuchi, Yoichiro Kobayashi and Madoka Furuhashi lead among researchers whose main affiliation is Japanese Red Cross Nagoya Daiichi Hospital.
- 1 Eiji Takeuchi Japan · #544,994 worldwide 105 citations · 84 works
- 2 Yoichiro Kobayashi Japan · #595,334 worldwide 26 citations · 25 works
- 3 Madoka Furuhashi Japan · #602,175 worldwide 49 citations · 24 works
- 4 Kanji Miyata Japan · #710,796 worldwide 25 citations · 31 works
- 5 Yasutomo Goto Japan · #750,887 worldwide 54 citations · 38 works
- 6 Tetsuya Nishida Japan · #780,224 worldwide 70 citations · 59 works
- 7 Haruki Sato Japan · #877,549 worldwide 3 citations · 18 works
- 8 Kaoru Ishikawa Japan · #919,836 worldwide 18 citations · 15 works
- 9 Norihiro Yuasa Japan · #1,035,300 worldwide 28 citations · 39 works
- 10 Hideo Miyake Japan · #1,044,488 worldwide 30 citations · 52 works
Which keywords describe research at Japanese Red Cross Nagoya Daiichi Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Treatment, Inflammation, Diagnosis, Clinical Practice Guidelines, Prognostic Factors and Gastric Cancer.
- Thrombosis
- Bone Marrow Niche
- Neoadjuvant Chemotherapy
- Colorectal Cancer
- Cytokines
- Prognosis
- Cardiovascular Risk
- Autoantibodies
- Tumor Microenvironment
- Endoscopic Resection
- Metastasis
- Molecular Characterization
- Hematopoietic Stem Cells
- Cancer
- Management
- Quality of Life
- Gastric Cancer
- Clinical Practice Guidelines
- Treatment
- Inflammation
- Epidemiology
- Chemotherapy
- Diagnosis
- Prognostic Factors
- Survival Analysis
- Immunotherapy
- Surgery
- Genetic Mutations
- Complications
- Surgical Management
- Adjuvant Therapy
- Mesenchymal Stem Cells
- Guidelines
- Neoadjuvant Therapy
- Prevention
- Prognostic Markers
- Cytoreductive Surgery
- Lymph Node Dissection
- Neurodevelopmental Outcomes
- Graft-versus-Host Disease
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology19▲ 3.3×57 topics
- Inflammation12▲ 4.1×32 topics
- Chemotherapy12▲ 11×20 topics
- Treatment11▲ 6.0×28 topics
- Diagnosis10▲ 7.1×25 topics
- Clinical Practice Guidelines8▲ 11×11 topics
- Prognostic Factors8▲ 13×12 topics
- Gastric Cancer7▲ 42×3 topics
- Survival Analysis7▲ 17×6 topics
- Quality of Life7▲ 3.1×21 topics
- Immunotherapy6▲ 5.8×16 topics
- Management6▲ 5.3×21 topics
- Surgery6▲ 11×11 topics
- Cancer6▲ 2.9×18 topics
- Genetic Mutations6▲ 8.8×17 topics
- Hematopoietic Stem Cells6▲ 44×3 topics
- Complications5▲ 7.0×9 topics
- Molecular Characterization5▲ 20×5 topics
- Surgical Management4▲ 7.4×15 topics
- Metastasis4▲ 8.8×7 topics
- Adjuvant Therapy4▲ 23×2 topics
- Endoscopic Resection4▲ 28×2 topics
- Mesenchymal Stem Cells4▲ 26×3 topics
- Tumor Microenvironment4▲ 6.3×6 topics
- Guidelines4▲ 5.8×9 topics
- Autoantibodies4▲ 11×6 topics
- Neoadjuvant Therapy4▲ 11×5 topics
- Cardiovascular Risk4▲ 7.7×5 topics
- Prevention4▲ 5.7×12 topics
- Prognosis4▲ 7.2×8 topics
- Prognostic Markers4▲ 22×3 topics
- Cytokines3▲ 8.3×3 topics
- Cytoreductive Surgery3▲ 35×2 topics
- Colorectal Cancer3▲ 28×2 topics
- Lymph Node Dissection3▲ 38×1 topic
- Neoadjuvant Chemotherapy3▲ 27×1 topic
- Neurodevelopmental Outcomes3▲ 12×6 topics
- Bone Marrow Niche3▲ 93×1 topic
- Graft-versus-Host Disease3▲ 93×1 topic
- Thrombosis3▲ 7.4×5 topics
Which research topics does Japanese Red Cross Nagoya Daiichi Hospital publish most on?
By volume in 2022–2025: Gastric Cancer Management and Outcomes, Hematopoietic Stem Cell Transplantation, Intraperitoneal and Appendiceal Malignancies and Cardiac Valve Diseases and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 3 works
- 2 Hematopoietic Stem Cell Transplantation Hematology 3 works
- 3 Intraperitoneal and Appendiceal Malignancies Surgery 3 works
- 4 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 2 works
- 5 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
- 6 Inflammatory Biomarkers in Disease Prognosis Oncology 2 works
- 7 Acute Myeloid Leukemia Research Hematology 2 works
- 8 Pelvic floor disorders treatments Rheumatology 2 works
- 9 Erythrocyte Function and Pathophysiology Physiology 2 works
- 10 Colorectal Cancer Surgical Treatments Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Japanese Red Cross Nagoya Daiichi Hospital's research output changed?
Output in 2018–2022 was 22% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nagoya
- Nagoya University
- Nagoya Institute of Technology
- Nagoya City University
- Meijo University
- Aichi Cancer Center
- Toyota Technological Institute
- Aichi Gakuin University
- Nagoya University Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.